TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10664935

Group type: EXPERIMENTAL
Intervention: Cord blood IgE levels in infants with obvious atopic disease
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: IgE levels at 12 months in infants with obvious atopy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: IgE levels in relation to male sex
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: IgE levels in relation to black race
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: IgE levels in relation to breast-feeding duration
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: IgE levels in relation to family income
Number of subjects: 114
Study: 7868711

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 200 mg itraconazole twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: 250 mg/day terbinafine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 200 mg/day itraconazole
Number of subjects: 30
Study: 2220995

Group type: EXPERIMENTAL
Intervention: Educational program using a handout as the only educational tool
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Educational program using a handout and a hands-on demonstration
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 18
Study: 326100

Group type: EXPERIMENTAL
Intervention: Portable laminar air-flow filter (Enviracaire)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no filter)
Number of subjects: 13
Study: 31128221

Group type: EXPERIMENTAL
Intervention: Approaches using post-randomized controlled trial data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stratified approach using post-trial data from participants taking the drug after trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combined initial trial and post-trial follow-up data
Number of subjects: 0
Study: 27436028

Group type: EXPERIMENTAL
Intervention: Particulate steroids
Number of subjects: 531

Group type: COMPARATOR
Intervention: Non-particulate steroids
Number of subjects: 531
Study: 25811109

Group type: EXPERIMENTAL
Intervention: L-glutamine (25 g)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Whole protein (25 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 24014905

Group type: EXPERIMENTAL
Intervention: Primaquine (15 mg single oral dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 12
Study: 22336008

Group type: EXPERIMENTAL
Intervention: Cluster schedule (6-week duration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional schedule (14-week duration)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cluster schedule
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional schedule
Number of subjects: 80

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 80
Study: 19152871

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 348

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 348
Study: 17224599

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Invasive needle control
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 15153172

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg once daily
Number of subjects: 893

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 800 mg once daily
Number of subjects: 893

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg three times daily
Number of subjects: 893

Group type: COMPARATOR
Intervention: Celecoxib 200 mg twice daily
Number of subjects: 893
Study: 11533321

Group type: EXPERIMENTAL
Intervention: Educational program for clinicians and parents
Number of subjects: 1136

Group type: COMPARATOR
Intervention: Control region (no educational intervention)
Number of subjects: 1136
Study: 9791684

Group type: EXPERIMENTAL
Intervention: Remantadine (1.5 mg/kg body weight 3 times a day for 3 days)
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Arbidole (10 mg/kg body weight in 4 portions for 5 days)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 802
Study: 1619184

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (Mg oxide) to bring Mg intake to 8 mg/kg body weight/day
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 26
Study: 6442713

Group type: EXPERIMENTAL
Intervention: 1000 ml of 10% Intralipid added to TPN over a period of 12 h (1.8‐2.1 g/kg/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: 24h TPN
Number of subjects: 26
Study: 28770459

Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg once daily for 24 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study: 29382803

Group type: EXPERIMENTAL
Intervention: Mechanical Thrombectomy After Intravenous Alteplase
Number of subjects: 53

Group type: COMPARATOR
Intervention: Alteplase Alone
Number of subjects: 53
Study: 26908003

Group type: EXPERIMENTAL
Intervention: Oropharyngeal airway based on maxillary incisors to the angle of the mandible
Number of subjects: 113

Group type: COMPARATOR
Intervention: Oropharyngeal airway based on corner of the mouth to the angle of the mandible
Number of subjects: 113
Study: 25204642

Group type: EXPERIMENTAL
Intervention: Ultrafine carbon particles (64 μg/m³; 6.1 ± 0.4 × 10⁵ particles/cm³ for 2 h)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 12
Study: 22494567

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/day
Number of subjects: 126
Study: 19578132

Group type: EXPERIMENTAL
Intervention: Supervised diet and exercise plus transdermal testosterone (50 mg once daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supervised diet and exercise alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Supervised diet and exercise plus transdermal testosterone
Number of subjects: 32
Study: 17538804

Group type: EXPERIMENTAL
Intervention: Cetaphil Moisturizing Cream applied twice daily for 15 days on one half of the face
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metronidazole 0.75% gel applied twice daily for at least 15 days
Number of subjects: 20
Study: 15045047

Group type: EXPERIMENTAL
Intervention: 250 mg azithromycin daily (high dose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 250 mg azithromycin twice weekly (low dose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both high and low dose azithromycin
Number of subjects: 14
Study: 11788107

Group type: EXPERIMENTAL
Intervention: 20-40 mg/day lovastatin
Number of subjects: 1555

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1555
Study: 9889712

Group type: EXPERIMENTAL
Intervention: Sodium chloride baths (30 and 50 g/l)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium chloride baths (50 g/l)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral baths (control group)
Number of subjects: 0
Study: 7701577

Group type: COMPARATOR
Intervention: OKT3 (5 mg/d)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: ATG-F (4 mg/kg/d)
Number of subjects: 104
Study: 2707058

Group type: EXPERIMENTAL
Intervention: Aerosolized metaproterenol delivered by metered‐dose inhaler (MDI) with a spacer device (Aerochamber)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Jet nebulizer delivering metaproterenol
Number of subjects: 44
Study: 321727

Group type: EXPERIMENTAL
Intervention: Droperidol (10 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 30940330

Group type: EXPERIMENTAL
Intervention: Audit feedback and service improvements implemented after July 2007
Number of subjects: 144

Group type: COMPARATOR
Intervention: Before feedback (2002-2007)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: After feedback (2007-2016)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Before feedback
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: After feedback
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Adjusted for patient characteristics after feedback
Number of subjects: 144
Study: 28378366

Group type: EXPERIMENTAL
Intervention: Enhanced patient-centered communication (E-PCC) style
Number of subjects: 190

Group type: COMPARATOR
Intervention: Low patient-centered communication (L-PCC) style
Number of subjects: 190
Study: 25262244

Group type: EXPERIMENTAL
Intervention: Computer-based food records
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Smartphone-based food records
Number of subjects: 18

Group type: COMPARATOR
Intervention: Paper-based food records
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall acceptability of food record methods
Number of subjects: 18
Study: 24063976

Group type: EXPERIMENTAL
Intervention: Sabin‐IPV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sabin‐IPV adjuvanted with aluminum hydroxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional IPV
Number of subjects: 0
Study: 21585365

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 19390545

Group type: EXPERIMENTAL
Intervention: Lenalidomide plus dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dexamethasone alone
Number of subjects: 0
Study: 16980741

Group type: EXPERIMENTAL
Intervention: Antioxidant agent administered into dental tissues after endo bleaching, cavity filled immediately.
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group with tooth cavity left open after endo bleaching, filled after 7 days.
Number of subjects: 169
Study: 17129330

Group type: EXPERIMENTAL
Intervention: Multifaceted, culturally competent intervention in nursing homes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12
Study: 10653232

Group type: EXPERIMENTAL
Intervention: Three 5-mm ports
Number of subjects: 141

Group type: COMPARATOR
Intervention: Two 10-mm ports and one 5-mm port
Number of subjects: 141
Study: 9284858

Group type: EXPERIMENTAL
Intervention: 40 mg/day citalopram alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 40 mg/day citalopram with brief psychosocial intervention
Number of subjects: 62
Study: 7890822

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.3-0.6 mg/kg/day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 85
Study: 3337561

Group type: EXPERIMENTAL
Intervention: Intraoperative radiation (IORT) combined with external beam irradiation and surgical resection, with or without 5-fluorouracil (5FU)
Number of subjects: 51
Study: 30825414

Group type: EXPERIMENTAL
Intervention: Participatory intervention using an online social network with weekly posters and active communication with mothers.
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Participatory intervention using an online social network.
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 251
Study: 29198191

Group type: EXPERIMENTAL
Intervention: Culturally appropriate multi-faceted oral health promotion intervention including anticipatory guidance, Motivational Interviewing, health and dental care for mothers during pregnancy and children at 6, 12, and 18 months.
Number of subjects: 454

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 454
Study: 26703489

Group type: COMPARATOR
Intervention: Monarch cartridge C
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Monarch cartridge D
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: IOL power less than 18.0 D
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: IOL power between 18.0 D to 23.5 D
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: IOL power over 23.5 D
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: IOL stress fractures
Number of subjects: 386
Study: 23782712

Group type: EXPERIMENTAL
Intervention: Axillary reverse mapping (ARM) during ALND
Number of subjects: 280

Group type: COMPARATOR
Intervention: Standard axillary lymph node dissection (ALND)
Number of subjects: 280
Study: 21320312

Group type: EXPERIMENTAL
Intervention: Theory-based interventions designed to improve adherence to TUPAC guidelines.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cluster randomised controlled design interventions.
Number of subjects: 0
Study: 19811918

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: RT + oral cyclophosphamide (RT+C)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Oral cyclophosphamide only (C)
Number of subjects: 367
Study: 16968397

Group type: EXPERIMENTAL
Intervention: IVIg therapy (2 g/kg body weight, monthly for 6 months)
Number of subjects: 6
Study: 15164224

Group type: EXPERIMENTAL
Intervention: Insulin (two types) injected subcutaneously
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11001240

Group type: EXPERIMENTAL
Intervention: Imipramine at a fixed, targeted, weight‐adjusted dose of 2.25 mg x kg(‐1) x day(‐1)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Imipramine treatment
Number of subjects: 110
Study: 9311358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Divalproex
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 32
Study: 8322488

Group type: EXPERIMENTAL
Intervention: 20 micrograms dose of influenza vaccine
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 10 micrograms dose of influenza vaccine
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 60 micrograms dose of influenza vaccine
Number of subjects: 79
Study: 3964359

Group type: EXPERIMENTAL
Intervention: Epi‐Lock polyurethane dressing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Silver sulfadiazene cream (Silvadene)
Number of subjects: 50
Study: 31489472

Group type: EXPERIMENTAL
Intervention: Stereotactic radiofrequency ablation (SRFA)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Matched controls (not specified)
Number of subjects: 177
Study: 30269076

Group type: EXPERIMENTAL
Intervention: Stationary state
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Driving state
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Speed bump section
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sudden stop section
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Right-hand cornering section
Number of subjects: 48
Study: 27834743

Group type: EXPERIMENTAL
Intervention: Endovascular treatment arm
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: INT occurrence
Number of subjects: 308
Study: 24605793

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg during the extension blinded Conversion Period (n=217)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg during weeks 1-13 of the extension Maintenance Period (n=181)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg during the extension
Number of subjects: 372
Study: 22672363

Group type: EXPERIMENTAL
Intervention: Diet high in fibre (>25 g/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diet low in fibre (<25 g/day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Diet high in fat (% of kcal/day fat intake)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Diet low in fibre (g/day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Diet low in carbohydrate (g/day)
Number of subjects: 42
Study: 22105257

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency endometrial ablation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Hydrothermablation
Number of subjects: 160
Study: 18327813

Group type: EXPERIMENTAL
Intervention: Aprepitant 125 mg orally on Day 1 followed by 80 mg on Days 2-3 (Arm A)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Aprepitant 125 mg orally on Day 1 and placebo on Days 2-3 (Arm B)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo on Days 1-3 (Arm C)
Number of subjects: 75
Study: 16598822

Group type: EXPERIMENTAL
Intervention: Professional coaching sessions addressing relationship tension
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Professional coaching sessions focusing on togetherness as a couple
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Professional coaching sessions discussing concerns about children
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Professional coaching sessions managing the threat of breast cancer
Number of subjects: 29
Study: 14640799

Group type: EXPERIMENTAL
Intervention: Involvement in caregiving activities by fathers
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Positive relationships reported by grandmothers with young parents
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Positive partner relationships reported by mothers
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Efforts to increase paternal involvement
Number of subjects: 148
Study: 11113045

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1558

Group type: EXPERIMENTAL
Intervention: Eptifibatide (within 72 hours of CABG)
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Placebo (within 72 hours of CABG)
Number of subjects: 1558

Group type: EXPERIMENTAL
Intervention: Eptifibatide (after 72 hours of CABG)
Number of subjects: 1558

Group type: COMPARATOR
Intervention: Placebo (after 72 hours of CABG)
Number of subjects: 1558
Study: 8888665

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg daily
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg daily
Number of subjects: 732

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU daily
Number of subjects: 732

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 732
Study: 1651213

Group type: EXPERIMENTAL
Intervention: Silicone fluid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-acting gas
Number of subjects: 0
Study: 6173522

Group type: EXPERIMENTAL
Intervention: Captopril 32.5 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Captopril 75 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Captopril 150 mg/day
Number of subjects: 12
Study: 31838486

Group type: EXPERIMENTAL
Intervention: Biofeedback (BF)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Manual Therapy (MT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Stretching (ST)
Number of subjects: 62
Study: 27995302

Group type: EXPERIMENTAL
Intervention: 0.1% tranexamic acid in irrigant fluid
Number of subjects: 400
Study: 26547425

Group type: EXPERIMENTAL
Intervention: GXR all-active (1-4 mg/day)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: GXR am (1-4 mg/day in the morning)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: GXR pm (1-4 mg/day in the evening)
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 23627550

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including mailed CRC screening test kits, low literacy patient education materials, automated phone and text message reminders, in-person follow up calls from a CRC Screening Coordinator, and communication of results to patients.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care including multiple point‐of‐care interventions (e.g., standing orders, EHR reminders), performance measurement, and financial incentives.
Number of subjects: 0
Study: 21565135

Group type: EXPERIMENTAL
Intervention: Suoquan Pill (SQP) 10 g per oral dose twice daily for 8 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Wuling Powder (WLP) 10 g per oral dose twice daily for 8 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo powder 10 g per oral dose twice daily for 8 weeks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Suoquan Pill (SQP) and Wuling Powder (WLP)
Number of subjects: 45
Study: 19276670

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy consisting of 2‐3 cycles of cisplatin and 5‐Fluorouracil followed by low dose weekly cisplatin based chemoradiotherapy (treatment arm: n = 48)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Chemoradiotherapy only (control arm: n = 57)
Number of subjects: 105
Study: 17888186

Group type: EXPERIMENTAL
Intervention: 400 mL/day of red wine for two weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (abstained from alcohol for two weeks)
Number of subjects: 40
Study: 15530198

Group type: EXPERIMENTAL
Intervention: High prior knowledge (HiPK) with well-structured texts
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Low prior knowledge (LoPK) with well-structured texts
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: High prior knowledge (HiPK) with less structured texts
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Low prior knowledge (LoPK) with less structured texts
Number of subjects: 195
Study: 11322056

Group type: EXPERIMENTAL
Intervention: 0.5% Apraclonidin eye drops applied twice daily for 8 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo medication (0.9% NaCI) applied according to the same protocol
Number of subjects: 10
Study: 9063761

Group type: COMPARATOR
Intervention: 19.3% glucose polymer solution (C trial)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 6.9% glucose polymer solution (D trial)
Number of subjects: 17
Study: 7938563

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 3296238

Group type: EXPERIMENTAL
Intervention: Intertransverse fusion with internal fixation
Number of subjects: 69

Group type: COMPARATOR
Intervention: No fusion
Number of subjects: 69
Study: 31548616

Group type: EXPERIMENTAL
Intervention: Self-initiated BP measurements
Number of subjects: 172

Group type: COMPARATOR
Intervention: Fully-automated BP measurements
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Self-initiated BP measurement
Number of subjects: 172

Group type: COMPARATOR
Intervention: Fully-automated self-measurement
Number of subjects: 172
Study: 29859224

Group type: EXPERIMENTAL
Intervention: Hall Technique (HT)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Non‐Restorative Cavity Control (NRCC)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional carious tissue removal and restoration (CR)
Number of subjects: 142